"cancer chemotherapeutic" trang 2 - tải miễn phí từ tailieunhanh
Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation

Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
10    38    1
Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity

Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity
14    49    1
Implication from thyroid function decreasing during chemotherapy in breast cancer patients: Chemosensitization role of triiodothyronine

Implication from thyroid function decreasing during chemotherapy in breast cancer patients: Chemosensitization role of triiodothyronine
12    31    1
“Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice

“Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice
12    28    1
Surgery alone, adjuvant tegafur/gimeracil/ octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: Real-world experience and a propensity score matching analysis

Surgery alone, adjuvant tegafur/gimeracil/ octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: Real-world experience and a propensity score matching analysis
14    46    1
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway

Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
16    60    3
Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer
16    2    1
AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway

AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway
13    1    1
Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line

Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
11    52    1
Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis

Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis
10    44    1
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)
8    54    1
Role of the splicing factor SRSF4 in cisplatininduced modifications of pre-mRNA splicing and apoptosis

Role of the splicing factor SRSF4 in cisplatininduced modifications of pre-mRNA splicing and apoptosis
14    42    1
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide

Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
12    37    1
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: Successive lines of active chemotherapeutic agents

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: Successive lines of active chemotherapeutic agents
8    36    2
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities

Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
14    27    1
Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors

Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors
16    36    1
TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/ HIF1α dependent manner

TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/ HIF1α dependent manner
10    23    1
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: A prospective single-arm trial (MiroCIP study)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: A prospective single-arm trial (MiroCIP study)
11    3    1
Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma
10    74    0
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy

Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
15    96    0